Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CL0043: An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

NCT05565599 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT05565599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05565599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CL0043: An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 21, 2022
Completion date
September 9, 2028
Enrollment
58 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation